Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

European Patient Summary

Patient
Name: Sacharczuk, , Aniela,
DOB: 02-NOV-1970 (Age: 55)
Gender: female
ID: 3843-787162-7 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 07-JAN-2025

Problem list

Condition Onset Date Status
Metabolic syndrome X 10-Dec-2019 active
Prediabetes 30-Oct-2012 active
Essential hypertension 02-Oct-2007 active

Medication list

Medication Since Form Dosage Reason
Lisinopril 10 mg oral tablet 2025-01-07 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 07-Jan-2025
Clostridium tetani toxoid antigen adsorbed only vaccine product 21-Dec-2021
Live attenuated Human alphaherpesvirus 3 only vaccine product 21-Dec-2021
SARS-CoV-2 mRNA vaccine 27-Apr-2021

Procedure History list

Procedure Date Reason
Radiography of ankle 22-Jun-2019 -
Bone immobilization 22-Jun-2019 Fracture of ankle
Medication reconciliation 17-Oct-2017 -
Assessment of health and social care needs 17-Oct-2017 -
Assessment of anxiety 17-Oct-2017 -
Screening for drug abuse 17-Oct-2017 -
Assessment of substance use 17-Oct-2017 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Diabetes self management plan 30-Oct-2012 Prediabetes
  • Achieve and maintain a healthy body weight to reduce risk of progression to diabetes.
  • Maintain hemoglobin A1c below 6.5% to prevent progression to diabetes.
  • Maintain blood pressure below 130/80 mmHg to reduce cardiovascular and diabetes risk.
  • Engage in at least 150 minutes of moderate-intensity physical activity per week.
Lifestyle education regarding hypertension 02-Oct-2007 Essential hypertension (disorder)
  • Reduce and maintain blood pressure below 130/80 mmHg through lifestyle modifications.
  • Lose at least 5% of baseline body weight to aid in hypertension management.
  • Engage in at least 150 minutes of moderate-intensity aerobic physical activity per week.
  • Limit dietary sodium intake to less than 2.3 grams per day.

Vital Signs

Vital Signs 2025-01-07 2024-01-02
Body Height 162.4 cm 162.4 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} 2 {score}
Body Weight 72.6 kg 72.6 kg
Body mass index (BMI) [Ratio] 27.5 kg/m2 27.5 kg/m2
Diastolic Blood Pressure 103 mm[Hg] 101 mm[Hg]
Systolic Blood Pressure 140 mm[Hg] 140 mm[Hg]
Heart rate 72 /min 99 /min
Respiratory rate 14 /min 15 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 07-JAN-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 76.8 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 10.1 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.8 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 142.9 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.1 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 109.6 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 23.5 22 - 29 mmol/L
Leukocytes [#/volume] in Blood by Automated count 5.2 3.4 - 10.6 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 4.0 L 4.2 - 5.2 10*6/uL
Hemoglobin [Mass/volume] in Blood 15.5 12 - 16 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 42.6 37 - 46 %
MCV [Entitic volume] by Automated count 83.4 80 - 105 fL
MCH [Entitic mass] by Automated count 30.9 27 - 34 pg
MCHC [Mass/volume] by Automated count 34.5 31 - 35 g/dL
Erythrocyte distribution width [Entitic volume] by Automated count 44.2 36 - 46 fL
Platelets [#/volume] in Blood by Automated count 343.7 150 - 415 10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count 451.4 H 11.6 - 17.4 fL
Platelet mean volume [Entitic volume] in Blood by Automated count 10.8 7.2 - 13.8 fL

Device Use

Device Date (since)
Blood glucose meter (physical object) 30-Oct-2012